Blog

- DISEASE ADVANCES

Lung cancer patient becomes tumor-free after treatment with selenite

A patient with advanced, treatment-resistant lung cancer became tumor-free after treatment with the selenium compound selenite. This is shown in a new study from Karolinska University Hospital and Karolinska Institutet published in the journal Oncology and Therapy as a case report. The findings may contribute to increased knowledge about selenite as a possible cancer treatment.

Read More »

Implantica receives FDA approval for RefluxStop® – Opening the U.S. market

VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for RefluxStop®, the company’s implant-based treatment for gastroesophageal reflux disease (GERD). The approval allows Implantica to begin commercial launch activities in the United States, the world’s largest medical device market.

Read More »

AI-calculated brain age predicts dementia risk years before doctors can see it

Memory clinics still rely on visual rating scales to assess brain atrophy, yet these tools lack the sensitivity to catch subtle changes associated with early dementia. A measure of how old a person’s brain appears on brain scans compared with their actual age might be a potential predictor of who is more likely to develop dementia over the years, reports a new study published in Neurology.

Read More »